AstraZeneca yesterday announced it had signed a five-year business process outsourcing (BPO) deal worth approximately $95 million (£47.4 million) to streamline its clinical data management.
The pharmaceutical giant, which last year signed a £684 million IT outsourcing deal with IBM, is intending to centralise the management and delivery of this key part of its business.
Eric Terhaerdt, AstraZeneca UK clinical development vice president and lead on this global project told IT PRO the decision to take on a BPO deal is new territory for the company. But an existing relationship with chosen BPO provider Cognizant mitigates any associated risk.
More
No comments:
Post a Comment